Vmg Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.16 M
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.51 Cr
- Revenue Growth -1.88%
- Profit Growth -43.35%
- Ebitda -47.98%
- Net Worth 3.59%
- Total Assets 7.28%
About Vmg Pharmaceuticals
Vmg Pharmaceuticals Private Limited (VPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 July 2008 and has a history of 16 years and six months. Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.16 M.
The company currently has active open charges totaling ₹1.51 Cr.
Amita Rajesh, Jose Campos, and Gauri Pandey serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100HR2008PTC092142
- Company No.
180997
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2008
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vmg Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amita Rajesh  | Additional Director | 31-Mar-2019 | Current |
Jose Campos  | Director | 05-Nov-2008 | Current |
| Gauri Pandey | Director | 02-Nov-2018 | Current |
Financial Performance of Vmg Pharmaceuticals.
Vmg Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.88% decrease. The company also saw a substantial fall in profitability, with a 43.35% decrease in profit. The company's net worth moved up by a moderate rise of 3.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vmg Pharmaceuticals?
In 2023, Vmg Pharmaceuticals had a public holding of 84.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹15.10 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.36 Cr
- Hdfc Bank Limited : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jan 2024 | Others | ₹2.40 M | Open |
| 01 Jan 2024 | Others | ₹4.00 M | Open |
| 01 Jan 2024 | Others | ₹7.20 M | Open |
| 13 Apr 2022 | Hdfc Bank Limited | ₹1.50 M | Open |
How Many Employees Work at Vmg Pharmaceuticals?
Unlock and access historical data on people associated with Vmg Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vmg Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vmg Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
